Citi Pharma Shareholders Approve Memorandum Change for Cannabis and Hemp Business
Citi Pharma shareholders have approved an amendment to the company’s Memorandum of Association, allowing it to undertake cannabis, industrial hemp and medicinal cannabis activities subject to regulatory approvals.
Citi Pharma Launches IPO for Veterinary Subsidiary to Expand Animal Health Business
Citi Pharma approves initial public offering for Citi Veterinary Pharma Limited, aiming to raise Rs. 1–2 billion and boost revenue in Pakistan’s veterinary pharmaceutical sector.
Citi Pharma Issues Clarification on Iraq Expansion Rumors to Counter Misinformation
Citi Pharma has officially denied reports about its alleged Iraq expansion plans, clarifying that no agreements or commitments have been made and urging media platforms to remove inaccurate information.